The Lack of Association Between Ubiquinol‐cytochrome C Reductase Core Protein I (UQCRC1) Variants and Parkinson's Disease in an Eastern Chinese Population
Zhihao Lin,Ran Zheng,Yang Ruan,Ting Gao,Chongyao Jin,Nai‐Jia Xue,Jia‐Xian Dong,Yaping Yan,Jun Tian,Jiali Pu,Baorong Zhang
DOI: https://doi.org/10.1111/cns.13436
2020-01-01
CNS Neuroscience & Therapeutics
Abstract:CNS Neuroscience & TherapeuticsVolume 26, Issue 9 p. 990-992 LETTER TO THE EDITOROpen Access The lack of association between ubiquinol-cytochrome c reductase core protein I (UQCRC1) variants and Parkinson's disease in an eastern Chinese population Zhi-Hao Lin, Zhi-Hao Lin orcid.org/0000-0002-2540-703X Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorRan Zheng, Ran Zheng Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorYang Ruan, Yang Ruan Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorTing Gao, Ting Gao Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorChong-Yao Jin, Chong-Yao Jin Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorNai-Jia Xue, Nai-Jia Xue Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorJia-Xian Dong, Jia-Xian Dong Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorYa-Ping Yan, Ya-Ping Yan Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorJun Tian, Jun Tian Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorJia-Li Pu, Corresponding Author Jia-Li Pu jialipu@zju.edu.cn orcid.org/0000-0002-6719-4060 Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China Correspondence Bao-Rong Zhang and Jia-Li Pu, Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China. Email: brzhang@zju.edu.cn; jialipu@zju.edu.cnSearch for more papers by this authorBao-Rong Zhang, Corresponding Author Bao-Rong Zhang brzhang@zju.edu.cn orcid.org/0000-0002-8099-7407 Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China Correspondence Bao-Rong Zhang and Jia-Li Pu, Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China. Email: brzhang@zju.edu.cn; jialipu@zju.edu.cnSearch for more papers by this author Zhi-Hao Lin, Zhi-Hao Lin orcid.org/0000-0002-2540-703X Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorRan Zheng, Ran Zheng Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorYang Ruan, Yang Ruan Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorTing Gao, Ting Gao Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorChong-Yao Jin, Chong-Yao Jin Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorNai-Jia Xue, Nai-Jia Xue Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorJia-Xian Dong, Jia-Xian Dong Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorYa-Ping Yan, Ya-Ping Yan Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorJun Tian, Jun Tian Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorJia-Li Pu, Corresponding Author Jia-Li Pu jialipu@zju.edu.cn orcid.org/0000-0002-6719-4060 Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China Correspondence Bao-Rong Zhang and Jia-Li Pu, Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China. Email: brzhang@zju.edu.cn; jialipu@zju.edu.cnSearch for more papers by this authorBao-Rong Zhang, Corresponding Author Bao-Rong Zhang brzhang@zju.edu.cn orcid.org/0000-0002-8099-7407 Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China Correspondence Bao-Rong Zhang and Jia-Li Pu, Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China. Email: brzhang@zju.edu.cn; jialipu@zju.edu.cnSearch for more papers by this author First published: 14 July 2020 https://doi.org/10.1111/cns.13436Citations: 3AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease, affecting approximately 2%-3% of the global population aged ≥65 years.1 The loss of dopaminergic (DA) neurons in the substantia nigral pars compacta (SNc) and intracellular α-synuclein deposition are known as PD's pivotal pathological characteristics. Although its etiology remains to be fully elucidated, the hypothesis that environmental and genetic factors play essential roles in the initiation and progression of PD is acknowledged worldwide.2 Over the past two decades, substantial progress has been made in our understanding of the genetic basis of parkinsonism through the identification of 19 monogenic disease-causing genes. In addition, emerging evidence suggests that some monogenic genes can also increase the risk of sporadic PD through different mechanisms.3 Previous studies have demonstrated that mitochondrial dysfunction plays a fundamental role in the pathogenesis of PD.4 Moreover, mitochondrial homeostasis has been related to mutations of Parkin, Pink1, and DJ-1.5 Ubiquinol-cytochrome c reductase core protein I (UQCRC1) is a component of the complex III in the respiratory chain complex. Recently, Lin et al used a whole-exome sequencing and discovered a novel candidate pathogenetic missense variant (c.941A > C p.Y314S) of the UQCRC1 gene in a Taiwanese family with autosomal dominant parkinsonism.6 To further investigate the association between UQCRC1 and PD in eastern China, we performed a UQCRC1 genetic analysis in a cohort of sporadic PD patients and healthy controls. We recruited 452 Chinese Han patients with sporadic PD and 450 sex-, age-, and ethnicity-matched healthy controls from the Second Affiliated Hospital of Zhejiang University (Hangzhou, China) between October 2016 and January 2019. All study participants were diagnosed according to the Movement Disorder Society clinical diagnostic criteria for PD.7 The basic information and demographic characteristics of participants are all shown in Data S1. All participants provided written informed consent. This study was approved by the Ethics Committee of the Second Affiliated Hospital of Zhejiang University of Medicine. Blood samples were obtained from all participants. Genomic DNA was then extracted from peripheral blood leukocytes using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. The exon and intron-exon boundaries of the UQCRC1 gene were amplified by polymerase chain reaction. Detailed information on primers and annealing temperature is shown in Data S2. DNA products were directly sequenced using a Genetic Analyzer (ABI 3730XL) and analyzed with Chromas software and Mutation Surveyor software (SoftGenetics). PD cases and healthy controls were matched for age and sex using a nonparametric test (Shapiro-Wilk normality test, P < .05) and Pearson's χ2 test, respectively. We also used Pearson's χ2 test, χ2 with Yates correction test or Fisher exact test to compare the allele frequencies in PD patients and healthy controls. The Hardy-Weinberg principle was used to ascertain the normal distribution of genotype frequencies in PD patients and healthy controls. Statistical analysis was performed using SPSS20.0 software (SPSS Inc). A two-tailed P < .05 was considered as threshold for statistical significance. The pathogenicity of missense variants was predicted using in silico tools including PolyPhen2, SIFT, CADD, as recommended by the American College of Medical Genetics and Genomics.8 In this study, we enrolled 452 sporadic PD cases and 450 healthy controls. There were no significant differences in age and sex distribution between patients and controls (Data S1). We identified three synonymous variants (p.V388=, p.A108=, and p.S473=) and four nonsynonymous variants (p.D215H, p.S4A, p.P267R, and p.N308S) of the UQCRC1 gene. The p.A108 = and p.S4A variants were detected exclusively in PD patients (Table 1). Moreover, the homozygous p.V388 = variant and the p.P267R variant were identified separately in two PD patients. However, we did not detect the previously reported p.Y314S variant (Lin et al, 2019). Analysis using publicly available resources indicated all four nonsynonymous variants should not be deleterious (Table 2). Furthermore, the frequencies of the seven variants showed no statistically significant differences between PD patients and controls. Representative images of the variants are presented in Data S3. TABLE 1. Variants identified in UQCRC1 in our study Chromosomal position Accession number Variant Number of carrying variants PD vs controls cDNA Amino acid PD Controls OR (95%CI) P Chr3:48637964 rs140583334 c.1164G>T p.V388= 42 40 1.050 (0.667-1.654) 0.833 Chr3:48642187 NA c.324C>T p.A108= 1 0 NA 1.000 Chr3:48636585 rs182453765 c.1419C>T p.S473= 12 14 0.849 (0.388-1.857) 0.682 Chr3:48641060 rs17080284 c.643G>C p.D215H 29 31 0.927 (0.549-1.565) 0.776 Chr3:48647044 NA c.10T > G p.S4A 1 0 NA 1.000 Chr3:48638807 rs149245457 c.800C>G p.P267R 22 15 1.484 (0.759-2.899) 0.245 Chr3:48638451 rs187641562 c.923A>G p.N308S 2 3 0.662 (0.110-3.982) 0.996 Abbreviations: CI, confidence interval; NA, not available; OR, odds ratio; P, P-value; PD, Parkinson's disease. TABLE 2. Allele frequencies and pathogenicity prediction of identified UQCRC1 missense variants Missense variants Freq.gnom AD(East Asian) Freq.ExAC (East Asian) Freq.1000G (East Asian) SIFT score Polyphen2 score CADD p.D215H 0.0291 0.0327 0.0238 0.097 0.997 25.4 p.S4A NA NA NA 0.274 0.175 12.69 p.P267R 0.0410 0.0360 0.0526 0.051 0.052 9 p.N308S 0.0034 0.0042 0.002 0.258 0.093 15.41 Note Threshold values for deleteriousness: SIFT <0.05; polyphen2 >0.86; CADD >15. Abbreviation: NA, not available. The UQCRC1 gene encodes ubiquinol-cytochrome c reductase core protein I, which is a subunit of complex III of the respiratory chain. As one of eleven subunits of complex III, UQCRC1 is a nuclear-encoded protein localized in the inner mitochondrial membrane. Previous studies of UQCRC1 have focused mainly on its roles in various tumors, such as malignant pleural mesothelioma and pancreatic ductal adenocarcinoma, suggesting that UQCRC1 may contribute to carcinogenesis.9, 10 Notably, mitochondrial dysfunction also plays a crucial role in the pathogenesis of PD.4, 11 Therefore, it can be hypothesized that UQCRC1 variants may play a role in the development of PD. Recently, UQCRC1 was identified as a candidate pathogenic gene for PD.6 Nevertheless, we did not find an association between sporadic PD and UQCRC1 in our study. Our data do not support that UQCRC1 mutation is a common genetic factor for sporadic patients in eastern China, but our study cannot rule out its pathogenic role in PD due to the limited ethnic background and sample size. Furthermore, in consideration of the role of outer mitochondrial membrane signaling in Parkinson's disease, proteins residing in or translocating to the outer mitochondrial membrane following mitochondrial activities deserve closer attention and be important in genetic analyses for PD.12 In conclusion, our study indicates that UQCRC1 may not be involved in pathogenesis of PD in eastern China. Further genetic analysis with larger sample sizes from diverse ethnic populations and functional assays are still needed to clarify the role of UQCRC1 in the pathogenesis of PD. ACKNOWLEDGMENTS We would like to express our gratitude to all the patients and their families who participated in this study. CONFLICT OF INTEREST The authors declare no conflicts of interest. FUNDING INFORMATION This work was supported by the National Natural Science Foundation of China (No. 81520108010 and 81771216) and the Primary Research and Development Plan of Zhejiang Province (No. 2020C03020). Supporting Information Filename Description cns13436-sup-0001-DataS1.docxWord document, 14.9 KB Data S1 cns13436-sup-0002-DataS2.docxWord document, 60.6 KB Data S2 cns13436-sup-0003-DataS3.docxWord document, 590.1 KB Data S3 Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. REFERENCES REFERENCES 1Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers. 2017; 3: 17013. CrossrefPubMedWeb of Science®Google Scholar 2Pang SY, Ho PW, Liu HF, et al. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease. Transl Neurodegener. 2019; 8: 23. CrossrefPubMedWeb of Science®Google Scholar 3Reed X, Bandres-Ciga S, Blauwendraat C, Cookson MR. The role of monogenic genes in idiopathic Parkinson's disease. Neurobiol Dis. 2019; 124: 230- 239. CrossrefCASPubMedWeb of Science®Google Scholar 4Grunewald A, Kumar KR, Sue CM. New insights into the complex role of mitochondria in Parkinson's disease. Prog Neurogibol. 2019; 177: 73- 93. CrossrefCASPubMedWeb of Science®Google Scholar 5Larsen SB, Hanss Z, Krüger R. The genetic architecture of mitochondrial dysfunction in Parkinson's disease. Cell Tissue Res. 2018; 373(1): 21- 37. CrossrefCASPubMedWeb of Science®Google Scholar 6Lin CH, Chen PL, Tai CH, et al. A clinical and genetic study of early-onset and familial parkinsonism in taiwan: an integrated approach combining gene dosage analysis and next-generation sequencing. Mov Disord. 2019; 34(4): 506- 515. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 7Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015; 30(12): 1591- 1601. Wiley Online LibraryPubMedWeb of Science®Google Scholar 8Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405- 423. CrossrefPubMedWeb of Science®Google Scholar 9Torricelli F, Saxena A, Nuamah R, et al. Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy. Eur J Cancer. 2020; 132: 104- 111. CrossrefCASPubMedWeb of Science®Google Scholar 10Wang Q, Li M, Gan Y, et al. Mitochondrial protein UQCRC1 is oncogenic and a potential therapeutic target for pancreatic cancer. Theranostics. 2020; 10(5): 2141- 2157. CrossrefCASPubMedWeb of Science®Google Scholar 11Cowan K, Anichtchik O, Luo S. Mitochondrial integrity in neurodegeneration. CNS Neurosci Ther. 2019; 25(7): 825- 836. Wiley Online LibraryPubMedWeb of Science®Google Scholar 12Lucero M, Suarez AE, Chambers JW. Phosphoregulation on mitochondria: Integration of cell and organelle responses. CNS Neurosci Ther. 2019; 25(7): 837- 858. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Citing Literature Volume26, Issue9September 2020Pages 990-992 ReferencesRelatedInformation